When Celera signed up Compaq in 1998, the company put a great deal of importance on the ability of various supercomputing systems to run a single gene-mapping program.
That may be good enough for mapping key signposts on chromosomes or rapidly locating a few key gene variations, says Venter, who recently joined the company's board.